Woking-based TT Electronics‘ rapid COVID-19 screening device Virolens has secured MHRA registration. Virolens is a rapid COVID-19 screening device for which TT is the exclusive manufacturing partner.
TT Electronics, a global provider of engineered electronics for performance critical applications, has confirmed that the Medicines and Healthcare products Regulatory Authority (MHRA), which is responsible for ensuring that medical devices meet applicable standards of safety, quality and efficacy, has registered Virolens for use and sale in Great Britain and British Start Up iAbra has been granted Certificates of Free Sale.
The Virolens system which provides test results for COVID-19 in 20 seconds was launched last year following successful trials at London Heathrow Airport. The Virolens COVID-19 screening device uses microscopic holographic imaging and artificial intelligence (AI) software technology to detect the presence of the COVID-19 virus from a non-intrusive saliva swab test within 20 seconds. The device does not need to be administered by healthcare professionals and is expected to be used in airports, offices, sports venues and many other locations where people need to be in close proximity to each other.
Revenues to TT from the sale of Virolens following the MHRA approval are dependent on iAbra’s potential end customers in Great Britain converting expressions of interest into firm orders.
A high proportion of the commercial interest in Virolens to date has been outside of Great Britain and any revenues resulting from this interest require further regulatory approval in those territories.
Following the announcement, Instant Covid Tests London (ICTL) has revealed it will launch the first test centre using the 20-second Virolens technology at The Brewery events space in the City of London, neighbouring thousands of workplaces.
On arrival, people will be promptly tested using the MHRA registered Virolens machine, which employs microscopic holographic imaging and artificial intelligence to detect the presence of the COVID-19 virus. It delivers a result within 20 seconds, making it the fastest screening device in the UK.
ICTL Marketing Director, Simon Lockwood, said: “Instant Covid Tests London is using Government-registered Virolens technology to allow many of London’s workers to safely return to their offices and workplaces. The technology is the first of its kind and a breakthrough in the battle against COVID-19.
“We’re proud to have used the Brewery events space to set up ICTL’s first test centre, which now offers our neighbouring workplaces a fast-track return to normality.
“We welcome enquiries from local businesses and individuals seeking immediate and highly-accurate COVID-19 test results delivered by trained and experienced diagnostics support staff.”
iAbra Founder, Greg Compton, said: “The Virolens technology is ground-breaking in its approach to screening for the virus. Whereas most COVID-19 testing technologies are based on chemistry, Virolens is based on physics.
“It successfully utilises artificial intelligence to image and identify the presence of a virus at a microscopic level in just seconds, without the need for a laboratory. This is a major step forward in the fight against COVID-19. “